Computer simulation

Launch of Ground-Breaking "Toward Good Simulation Practice" Book to Set New Standards in Biomedical Simulation

Retrieved on: 
Monday, March 4, 2024

CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.

Key Points: 
  • CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
  • The book underscores the necessity for guidelines akin to the GxP standards, yet specifically tailored for in silico methodologies.
  • It leverages the ASMEV&V40 – 2018 standard as a model, proposing a consensus-driven framework to support CM&S with good practices applicable across the spectrum of medical solutions.
  • This partnership illustrates the proactive engagement between regulatory agencies and the scientific community to foster advancements in medical product development.

Launch of Ground-Breaking "Toward Good Simulation Practice" Book to Set New Standards in Biomedical Simulation

Retrieved on: 
Monday, March 4, 2024

CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.

Key Points: 
  • CM&S is also a very promising technology into the broader narrative of advancing regulatory science and healthcare innovation.
  • The book underscores the necessity for guidelines akin to the GxP standards, yet specifically tailored for in silico methodologies.
  • It leverages the ASMEV&V40 – 2018 standard as a model, proposing a consensus-driven framework to support CM&S with good practices applicable across the spectrum of medical solutions.
  • This partnership illustrates the proactive engagement between regulatory agencies and the scientific community to foster advancements in medical product development.

GrayMatters Health Announces Pioneering Study Highlighting Safety and Efficacy of Self-Neuromodulation for PTSD

Retrieved on: 
Tuesday, February 6, 2024

HAIFA, Israel and NEW YORK, Feb. 6, 2024 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, announces the publication of a peer-reviewed article in the Journal of Psychiatry Research demonstrating the safety and efficacy of its FDA-cleared Prism for PTSD device. The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).

Key Points: 
  • The prospective, single arm, multi-site, open label trial evaluated men, women, and treatment-resistant combat veterans with chronic post-traumatic stress disorder (PTSD).
  • Prism for PTSD is the first self-neuromodulation device to receive FDA clearance as a prescribed adjunct to standard-of-care for PTSD.
  • The treatment, now available in select clinics in the United States, digitizes brain activity associated with PTSD to scientifically help patients gain control of their PTSD symptoms.
  • Prism for PTSD uses a computer simulation and EEG headset to create a novel, immersive environment for training individuals to self-modulate an amygdala-based biomarker associated with PTSD.

Clinical Utility of FEops AI-enabled Predictive Pre-planning for LAAO Demonstrated in US

Retrieved on: 
Friday, February 2, 2024

“This is the first-ever comprehensive clinical evaluation in the US proving that Artificial Intelligence (AI)-enabled predictive pre-planning significantly improves LAAO procedural efficiency for both the Watchman FLX and the Amulet device.

Key Points: 
  • “This is the first-ever comprehensive clinical evaluation in the US proving that Artificial Intelligence (AI)-enabled predictive pre-planning significantly improves LAAO procedural efficiency for both the Watchman FLX and the Amulet device.
  • In terms of procedural efficiency, the evaluation results revealed that in 97% cases a single LAAO device was successfully implanted with a single transseptal puncture.
  • “This real world evidence clearly reinforces the value of our pioneering digital twin strategy to alter the course of heart disease,” said Matthieu De Beule, co-founder and CEO of FEops.
  • Together we continue to advance how physicians access therapy options for patients at risk of stroke due to atrial fibrillation.

Prince George School Fair's on a Mission to Help Families Find, Evaluate, and Choose Great Schools

Retrieved on: 
Saturday, January 20, 2024

PRINCE GEORGE COUNTY, Md., Jan. 20, 2024 /PRNewswire/ -- A school fair highlighting local public, private, and extracurricular learning options returns to Prince George County this Sunday, Jan. 28. Join Prince George families for a day of kid-friendly fun, parent workshops, and free food. 

Key Points: 
  • Join Prince George families for a day of kid-friendly fun, parent workshops, and free food.
  • Hosted by Prince George Parents Alliance for Educational Options and the Black Student Fund, the free school fair will take place 2-5 p.m. at Bishop McNamara High School and feature booths from more than 40 local school options.
  • Workshops will engage parents and guardians on subjects such as "Paying for Independent School Education" while children enjoy a DJ, face painting, and additional fun.
  • "This in person and virtual event will provide Maryland families with information that makes school choice a reality," said Leroy Nesbitt of the Black Student Fund.

GrayMatters Health Launches New FDA-Cleared Self-Neuromodulation PTSD Therapy in the United States

Retrieved on: 
Thursday, January 4, 2024

HAIFA, Israel, Jan. 4, 2024 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, announces the official launch of Prism for PTSD in the United States. Prism for PTSD is currently being used to treat patients at two centers, with additional clinics in various phases of readiness.

Key Points: 
  • Prism for PTSD Digitizes Brain Activity Associated with PTSD, Giving Patients Skills to Address Symptoms
    HAIFA, Israel, Jan. 4, 2024 /PRNewswire/ -- GrayMatters Health (GMH) , developer of digital self-neuromodulation therapies for mental health care, announces the official launch of Prism for PTSD in the United States.
  • Prism for PTSD is currently being used to treat patients at two centers, with additional clinics in various phases of readiness.
  • 13 million Americans struggle with post-traumatic stress disorder (PTSD) following assault, abuse, military combat, illness, accident, or natural disasters.
  • Prism for PTSD utilizes an amygdala-based biomarker since research has shown that PTSD is associated with hyper-activity of the amygdala.

Qubit Pharmaceuticals and Sorbonne University achieve a major scientific breakthrough by simulating quantum calculations at more than 40 qubits on conventional computers

Retrieved on: 
Wednesday, December 6, 2023

Qubit Pharmaceuticals introduces its Hyperion-1 emulator, developed in close collaboration with Sorbonne University and capable of running accelerated and accurate quantum algorithms at over 40 qubits.

Key Points: 
  • Qubit Pharmaceuticals introduces its Hyperion-1 emulator, developed in close collaboration with Sorbonne University and capable of running accelerated and accurate quantum algorithms at over 40 qubits.
  • Paris, December 6th, 2023 - Qubit Pharmaceuticals, a deeptech company specializing in the discovery of new drug candidates through molecular simulation and modeling accelerated by hybrid HPC and quantum computing, announces a major scientific breakthrough after achieving quantum computations simulating 40 qubits with its new Hyperion-1 emulator.
  • This achievement reinforces Qubit Pharmaceuticals' ambition to become the industry reference in molecular modeling-based drug discovery.
  • Exceptional performance: Hyperion-1 has demonstrated outstanding performance in high-speed simulations of complex quantum circuits of up to 40 qubits, using moderate computing resources, i.e.

University of Stuttgart and Hewlett Packard Enterprise to Build Exascale Supercomputer

Retrieved on: 
Tuesday, December 19, 2023

The University of Stuttgart and Hewlett Packard Enterprise (NYSE: HPE) have announced an agreement to build two new supercomputers at the High-Performance Computing Center of the University of Stuttgart ( HLRS ).

Key Points: 
  • The University of Stuttgart and Hewlett Packard Enterprise (NYSE: HPE) have announced an agreement to build two new supercomputers at the High-Performance Computing Center of the University of Stuttgart ( HLRS ).
  • Hunter will be based on the HPE Cray EX4000 supercomputer, which is designed to deliver exascale performance to support large-scale workloads across modeling, simulation, AI, and HPDA.
  • We look forward to building on our collaboration to pave the way to exascale for HLRS using the HPE Cray EX supercomputer.
  • We are particularly excited that we have found a globally leading partner for these topics in Hewlett Packard Enterprise, who together with AMD will open up new horizons of performance for our clients.”

WiMi Integrated Deep Learning Algorithm into Multi-Depth Hologram Generation

Retrieved on: 
Wednesday, November 15, 2023

BEIJING, Nov. 15, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it integrated deep learning algorithm into multi-depth hologram generation to extract the depth information of the 3D scene from the input 2D image and convert it into a hologram to realize multi-depth hologram generation.

Key Points: 
  • BEIJING, Nov. 15, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that it integrated deep learning algorithm into multi-depth hologram generation to extract the depth information of the 3D scene from the input 2D image and convert it into a hologram to realize multi-depth hologram generation.
  • The deep learning algorithm is the key to the multi-depth hologram generation.
  • The advantage of the multi-depth hologram generation technology based on the deep learning algorithm is that it can generate holograms through computer simulation, avoiding the complex process of traditional hologram production.
  • In the future, WiMi will also continue to explore the field of multi-depth hologram generation algorithms and promote the multi-depth hologram generation technology based on deep learning algorithms to achieve greater breakthroughs and applications.

GrayMatters Health Wins 2023 Prix Galien USA Best Startup Award

Retrieved on: 
Wednesday, November 1, 2023

HAIFA, Israel, Nov. 1, 2023 /PRNewswire/ -- GrayMatters Health (GMH), developer of digital self-neuromodulation therapies for mental health care, today announced it has been named the 2023 Prix Galien USA Best Startup winner. The Prix Galien Awards honors excellence and innovation in life sciences and are regarded worldwide as the equivalent of the Nobel Prize for the life science industry. GMH was recognized for its work creating and developing Prism for PTSD, the first self-neuromodulation therapy to receive U.S. FDA 510(k) clearance as a prescribed adjunct therapy for PTSD, now available in select clinics in the US.

Key Points: 
  • HAIFA, Israel, Nov. 1, 2023 /PRNewswire/ -- GrayMatters Health (GMH) , developer of digital self-neuromodulation therapies for mental health care, today announced it has been named the 2023 Prix Galien USA Best Startup winner.
  • The Prix Galien Awards honors excellence and innovation in life sciences and are regarded worldwide as the equivalent of the Nobel Prize for the life science industry.
  • Prism introduces a new mental health treatment modality featuring the world's first digital EEG-fMRI-Pattern (EFP) biomarker, which applies advanced statistical models that register fMRI data with standard EEG data.
  • As patients identify a personal memory, emotion or experience to control the simulation, Prism measures their amygdala-based EFP biomarker.